前收市價 | 0.8800 |
開市 | 0.8000 |
買盤 | 0.7200 |
賣出價 | 0.7900 |
拍板 | 32.50 |
到期日 | 2025-01-17 |
今日波幅 | 0.6700 - 0.8000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 29.71k |
Moderna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19 variant JN.1 to the FDA for the upcoming vaccination season.
Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.